1-17 of 17
David Raben
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract IA25: Radiation as a way to flip the switch: Resistance to responder in HNSCC

David Raben
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (12_Supplement_2): IA25.
https://doi.org/10.1158/1557-3265.AACRAHNS19-IA25
Published: 15 June 2020
View article titled, Abstract IA25: Radiation as a way to flip the switch: Resistance to responder in HNSCC
Journal Articles

PARP Inhibition Enhances Radiotherapy of SMAD4-Deficient Human Head and Neck Squamous Cell Carcinomas in Experimental Models

Ariel L. Hernandez, Christian D. Young, Li Bian, Kelsey Weigel, Kyle Nolan, Barbara Frederick, Gangwen Han, Guanting He, G. Devon Trahan, Michael C. Rudolph, Kenneth L. Jones, Ayman J. Oweida, Sana D. Karam, David Raben, Xiao-Jing Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (12): 3058–3070.
https://doi.org/10.1158/1078-0432.CCR-19-0514
Published: 15 June 2020
View article titled, PARP Inhibition Enhances Radiotherapy of SMAD4-Deficient Human Head and Neck Squamous Cell Carcinomas in Experimental Models
Open the PDF for PARP Inhibition Enhances Radiotherapy of SMAD4-Deficient Human Head and Neck Squamous Cell Carcinomas in Experimental Models in another window
Includes: Supplementary data
Journal Articles

Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination

Shelby Lennon, Ayman Oweida, Dallin Milner, Andy V. Phan, Shilpa Bhatia, Benjamin Van Court, Laurel Darragh, Adam C. Mueller, David Raben, Jorge L. Martínez-Torrecuadrada, Todd M. Pitts, Hilary Somerset, Kimberly R. Jordan, Kirk C. Hansen, Jason Williams, Wells A. Messersmith, Richard D. Schulick, Philip Owens, Karyn A. Goodman, Sana D. Karam
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (11): 3352–3365.
https://doi.org/10.1158/1078-0432.CCR-18-2811
Published: 03 June 2019
View article titled, Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination
Open the PDF for Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination in another window
Includes: Supplementary data
Journal Articles

Smad7 Promotes Healing of Radiotherapy-Induced Oral Mucositis without Compromising Oral Cancer Therapy in a Xenograft Mouse Model

Jingjing Luo, Li Bian, Melanie A. Blevins, Dongyan Wang, Chao Liang, Danfeng Du, Fanglong Wu, Barry Holwerda, Rui Zhao, David Raben, Hongmei Zhou, Christian D. Young, Xiao-Jing Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (2): 808–818.
https://doi.org/10.1158/1078-0432.CCR-18-1081
Published: 15 January 2019
View article titled, Smad7 Promotes Healing of Radiotherapy-Induced Oral Mucositis without Compromising Oral Cancer Therapy in a Xenograft Mouse Model
Open the PDF for Smad7 Promotes Healing of Radiotherapy-Induced Oral Mucositis without Compromising Oral Cancer Therapy in a Xenograft Mouse Model in another window
Includes: Supplementary data
Journal Articles

The Integration of Radiotherapy with Immunotherapy for the Treatment of Non–Small Cell Lung Cancer

Eric C. Ko, David Raben, Silvia C. Formenti
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (23): 5792–5806.
https://doi.org/10.1158/1078-0432.CCR-17-3620
Published: 03 December 2018
View article titled, The Integration of Radiotherapy with Immunotherapy for the Treatment of Non–Small Cell Lung Cancer
Open the PDF for The Integration of Radiotherapy with Immunotherapy for the Treatment of Non–Small Cell Lung Cancer in another window
Journal Articles

Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration

Ayman Oweida, Mohammad K. Hararah, Andy Phan, David Binder, Shilpa Bhatia, Shelby Lennon, Sanjana Bukkapatnam, Benjamin Van Court, Nomin Uyanga, Laurel Darragh, Hyun Min Kim, David Raben, Aik Choon Tan, Lynn Heasley, Eric Clambey, Raphael Nemenoff, Sana D. Karam
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (21): 5368–5380.
https://doi.org/10.1158/1078-0432.CCR-18-1038
Published: 01 November 2018
View article titled, Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration
Open the PDF for Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration in another window
Includes: Supplementary data
Journal Articles

Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer

Sana D. Karam, Krishna Reddy, Patrick J. Blatchford, Tim Waxweiler, Alicia M. DeLouize, Ayman Oweida, Hilary Somerset, Carrie Marshall, Christian Young, Kurtis D. Davies, Madeleine Kane, Aik Choo Tan, Xiao Jing Wang, Antonio Jimeno, Dara L. Aisner, Daniel W. Bowles, David Raben
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (20): 4949–4959.
https://doi.org/10.1158/1078-0432.CCR-18-0467
Published: 15 October 2018
View article titled, Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer
Open the PDF for Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer in another window
Includes: Supplementary data
Journal Articles

Inhibition of EphB4–Ephrin-B2 Signaling Enhances Response to Cetuximab–Radiation Therapy in Head and Neck Cancers

Shilpa Bhatia, Jaspreet Sharma, Sanjana Bukkapatnam, Ayman Oweida, Shelby Lennon, Andy Phan, Dallin Milner, Nomin Uyanga, Antonio Jimeno, David Raben, Hilary Somerset, Lynn Heasley, Sana D. Karam
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (18): 4539–4550.
https://doi.org/10.1158/1078-0432.CCR-18-0327
Published: 14 September 2018
View article titled, Inhibition of EphB4–Ephrin-B2 Signaling Enhances Response to Cetuximab–Radiation Therapy in Head and Neck Cancers
Open the PDF for Inhibition of EphB4–Ephrin-B2 Signaling Enhances Response to Cetuximab–Radiation Therapy in Head and Neck Cancers in another window
Includes: Supplementary data
Journal Articles

Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017

Paul Okunieff, Katherine Casey-Sawicki, Natalie A. Lockney, Bradford S. Hoppe, Heiko Enderling, Chelsea Pinnix, James Welsh, Sunil Krishnan, Greg Yothers, Martin Brown, Susan Knox, Robert Bristow, Paul Spellman, Timur Mitin, Nima Nabavizadeh, Jerry Jaboin, H. Charles Manning, Felix Feng, Susan Galbraith, Abhishek A. Solanki, Matthew M. Harkenrider, Richard Tuli, Roy H. Decker, Steven E. Finkelstein, Charles C. Hsu, Chul S. Ha, Reshma Jagsi, Dean Shumway, Megan Daly, Tony J.C. Wang, Thomas J. Fitzgerald, Fran Laurie, David T. Marshall, David Raben, Louis Constine, Charles R. Thomas, Jr, Lisa A. Kachnic
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (15): 3500–3509.
https://doi.org/10.1158/1078-0432.CCR-17-3202
Published: 31 July 2018
View article titled, Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017
Open the PDF for Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017 in another window
Journal Articles

A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma

Thomas J. Galloway, Lori J. Wirth, Alexander D. Colevas, Jill Gilbert, Julie E. Bauman, Nabil F. Saba, David Raben, Ranee Mehra, Anna W. Ma, Ruzanna Atoyan, Jing Wang, Barbara Burtness, Antonio Jimeno
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (7): 1566–1573.
https://doi.org/10.1158/1078-0432.CCR-14-2820
Published: 31 March 2015
View article titled, A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma
Open the PDF for A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Fibroblast Growth Factor Receptors Are Components of Autocrine Signaling Networks in Head and Neck Squamous Cell Carcinoma Cells

Marianne E. Marshall, Trista K. Hinz, Scott A. Kono, Katherine R. Singleton, Brady Bichon, Kathryn E. Ware, Lindsay Marek, Barbara A. Frederick, David Raben, Lynn E. Heasley
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (15): 5016–5025.
https://doi.org/10.1158/1078-0432.CCR-11-0050
Published: 31 July 2011
View article titled, Fibroblast Growth Factor Receptors Are Components of Autocrine Signaling Networks in Head and Neck Squamous Cell Carcinoma Cells
Open the PDF for Fibroblast Growth Factor Receptors Are Components of Autocrine Signaling Networks in Head and Neck Squamous Cell Carcinoma Cells in another window
Includes: Supplementary data
Journal Articles

Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008

Paul Okunieff, Lisa A. Kachnic, Louis S. Constine, Clifton D. Fuller, Laurie E. Gaspar, Daniel F. Hayes, Jean Hooks, Clifton Ling, Frank L. Meyskens, Jr., Philip A. Philip, David Raben, Stephen R. Smalley, Gregory P. Swanson, Beverly A. Teicher, Charles R. Thomas, Jr., Bhadrasain Vikram, Michael J. Zelefsky, Laurence H. Baker
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (18): 5663–5670.
https://doi.org/10.1158/1078-0432.CCR-09-0357
Published: 14 September 2009
View article titled, Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008
Open the PDF for Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008 in another window
Journal Articles

Synergistic Antitumor Activity of ZD6474, An Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor Signaling, with Gemcitabine and Ionizing Radiation against Pancreatic Cancer

Cataldo Bianco, Elisa Giovannetti, Fortunato Ciardiello, Valentina Mey, Sara Nannizzi, Giampaolo Tortora, Teresa Troiani, Francesco Pasqualetti, Gail Eckhardt, Mario de Liguoro, Simona Ricciardi, Mario Del Tacca, David Raben, Luca Cionini, Romano Danesi
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (23): 7099–7107.
https://doi.org/10.1158/1078-0432.CCR-06-0833
Published: 04 December 2006
View article titled, Synergistic Antitumor Activity of ZD6474, An Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor Signaling, with Gemcitabine and Ionizing Radiation against Pancreatic Cancer
Open the PDF for Synergistic Antitumor Activity of ZD6474, An Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor Signaling, with Gemcitabine and Ionizing Radiation against Pancreatic Cancer in another window
Journal Articles

Antitumor Activity of the Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Gefitinib (ZD1839, Iressa) in Non–Small Cell Lung Cancer Cell Lines Correlates with Gene Copy Number and EGFR Mutations but not EGFR Protein Levels

Barbara A. Helfrich, David Raben, Marileila Varella-Garcia, Dan Gustafson, Daniel C. Chan, Lynne Bemis, Chris Coldren, Anna Barón, Chan Zeng, Wilbur A. Franklin, Fred R. Hirsch, Adi Gazdar, John Minna, Paul A. Bunn, Jr.
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (23): 7117–7125.
https://doi.org/10.1158/1078-0432.CCR-06-0760
Published: 04 December 2006
View article titled, Antitumor Activity of the Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Gefitinib (ZD1839, Iressa) in Non–Small Cell Lung Cancer Cell Lines Correlates with Gene Copy Number and EGFR Mutations but not EGFR Protein Levels
Open the PDF for Antitumor Activity of the Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Gefitinib (ZD1839, Iressa) in Non–Small Cell Lung Cancer Cell Lines Correlates with Gene Copy Number and EGFR Mutations but not EGFR Protein Levels in another window
Journal Articles

Cooperative Antitumor Effect of Multitargeted Kinase Inhibitor ZD6474 and Ionizing Radiation in Glioblastoma

Vincenzo Damiano, Davide Melisi, Cataldo Bianco, David Raben, Rosa Caputo, Gabriella Fontanini, Roberto Bianco, Anderson Ryan, A. Raffaele Bianco, Sabino De Placido, Fortunato Ciardiello, Giampaolo Tortora
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (15): 5639–5644.
https://doi.org/10.1158/1078-0432.CCR-05-0174
Published: 01 August 2005
View article titled, Cooperative Antitumor Effect of Multitargeted Kinase Inhibitor ZD6474 and Ionizing Radiation in Glioblastoma
Open the PDF for Cooperative Antitumor Effect of Multitargeted Kinase Inhibitor ZD6474 and Ionizing Radiation in Glioblastoma in another window
Journal Articles

The Effects of Cetuximab Alone and in Combination With Radiation and/or Chemotherapy in Lung Cancer

David Raben, Barb Helfrich, Daniel C. Chan, Fortunato Ciardiello, LiMin Zhao, Wilbur Franklin, Anna E. Barón, Chan Zeng, Tim K. Johnson, Paul A. Bunn, Jr
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (2): 795–805.
https://doi.org/10.1158/1078-0432.795.11.2
Published: 08 February 2005
View article titled, The Effects of Cetuximab Alone and in Combination With Radiation and/or Chemotherapy in Lung Cancer
Open the PDF for The Effects of Cetuximab Alone and in Combination With Radiation and/or Chemotherapy in Lung Cancer in another window
Journal Articles

Enhancement of Antitumor Activity of Ionizing Radiation by Combined Treatment with the Selective Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor ZD1839 (Iressa)

Cataldo Bianco, Giampaolo Tortora, Roberto Bianco, Roberta Caputo, Bianca Maria Veneziani, Rosa Caputo, Vincenzo Damiano, Teresa Troiani, Gabriella Fontanini, David Raben, Stefano Pepe, A. Raffaele Bianco, Fortunato Ciardiello
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (10): 3250–3258.
Published: 01 October 2002
View article titled, Enhancement of Antitumor Activity of Ionizing Radiation by Combined Treatment with the Selective Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor ZD1839 (Iressa)
Open the PDF for Enhancement of Antitumor Activity of Ionizing Radiation by Combined Treatment with the Selective Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor ZD1839 (Iressa) in another window